Aerial image of KU Medical Center's Kansas City campus with text overlaid reading, The University of Kansas Hematology and Medical Oncology Review. Logos of KU Medical Center, The University of Kansas Cancer Center and NCI appear at the bottom
Saturday, June 22, 2024
OVERVIEW
The 2024 Hematology and Medical Oncology Review will focus on disseminating state-of-the-art information from several major national meetings that have occurred within the last year, including:
  • the Annual Meeting of the American Society of Clinical Oncology (ASCO),
  • The San Antonio Breast Cancer Symposium (SABC), and
  • the American Society of Hematology Review (ASH).
Nationally known speakers as well as our KU experts will present the most recent practice-changing trial data in the field of hematology and medical oncology. Presenters will discuss crucial data with health care professionals treating and managing patients regarding hematological malignancies and solid tumors. 
TARGET AUDIENCE
This symposium is designed for practicing medical oncologists, radiation oncologists, oncology surgeons, hematologists, advanced practice providers, pharmacists, oncology nurses and other health care providers involved in the care of hematology and oncology patients in the region.
REGISTER NOW
KEYNOTE SPEAKERS 
Portrait of Robert Haddad

Robert Haddad, M.D.
Topic: Head and Neck Cancer Treatment Updates
Chief, Division of Head and Neck Oncology and McGraw Chair in Head and Neck Oncology; Professor of Medicine at Harvard Medical School
Institute Physician at Dana Farber Cancer Institute
Portrait of Hamza Hashmi

Hamza Hashmi, M.D.
Topic: Updates in Myeloma Management
Assistant Attending at Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine at Weill Cornell Medical College
Portrait of Corey Langer

Corey J. Langer, M.D.
Topic: NSCLC: Advances in Therapy
Professor of Medicine, Department of Medicine, Division of Hematology Oncology, Perelman Center for Advanced Medicine at The Hospital of the University of Pennsylvania
Portrait of Alice Minns

Alice Mims, M.D., MSCR
Topic: Leukemia and Myeloid Malignancies
Professor of Internal Medicine, Research Section Head of Acute Leukemia/Myeloid Malignancies, Division of Hematology at The Ohio State University
EVENT DETAILS
Saturday, June 22, 2024, 8 a.m. to 4 p.m.
Sheraton Overland Park Hotel at the Convention Center
6100 College Boulevard, Overland Park, KS 66211
Join us for a daylong conference featuring presentations on an array of topics and Q&A sessions with esteemed panelists from the University of Kansas Medical Center and other national leaders in the field of hematology and medical oncology.
VIEW FULL SCHEDULE
ACCREDITATION
In support of improving patient care, the University of Kansas Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. 
Course objectives, credit statement and disclosures can be found at eeds.com/live/569647
Logo of the Jointly Accredited Provider
KU Medical Center logo
Logo of KU Cancer Center

NCI Comprehensive Cancer Center logo
3901 Rainbow Boulevard, Kansas City, KS 66160  |  913-588-5000